4//SEC Filing
Sims Andrew John Hugh MacIntyre 4
Accession 0000950170-25-109409
CIK 0001095981other
Filed
Aug 14, 8:00 PM ET
Accepted
Aug 15, 4:29 PM ET
Size
7.8 KB
Accession
0000950170-25-109409
Insider Transaction Report
Form 4
Sims Andrew John Hugh MacIntyre
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-08-13+1,379,636→ 1,379,636 totalExercise: $0.57Exp: 2035-08-12→ Common Stock (1,379,636 underlying) - Award
Restricted Stock Units
2025-08-13+459,878→ 459,878 total→ Common Stock (459,878 underlying)
Footnotes (2)
- [F1]The option vest over four years in equal 1/48th increments on each monthly anniversary of the issuance.
- [F2]The Restricted Stock Units (RSUs) awarded on August 13, 2025 vest over three years, with 1/3rd vesting on the first anniversary of the Grant Date and the remaining 2/3rds vesting in equal monthly installments over the following two years. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.
Documents
Issuer
PLUS THERAPEUTICS, INC.
CIK 0001095981
Entity typeother
Related Parties
1- filerCIK 0001802687
Filing Metadata
- Form type
- 4
- Filed
- Aug 14, 8:00 PM ET
- Accepted
- Aug 15, 4:29 PM ET
- Size
- 7.8 KB